P/E ratio for JD Health (6618.HK)
P/E ratio at the end of 2024: 19.9
According to JD Health 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 34.3014. At the end of 2024 the company had a P/E ratio of 19.9.
P/E ratio history for JD Health from 2020 to 2024
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2024 | 19.9 | -61.08% |
| 2023 | 51.0 | -90.23% |
| 2022 | 522 | -480.16% |
| 2021 | -137 | 750.95% |
| 2020 | -16.1 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.